UK markets close in 3 hours 31 minutes
  • FTSE 100

    6,974.25
    -44.35 (-0.63%)
     
  • FTSE 250

    17,707.49
    -265.20 (-1.48%)
     
  • AIM

    827.61
    -5.98 (-0.72%)
     
  • GBP/EUR

    1.1185
    -0.0004 (-0.04%)
     
  • GBP/USD

    1.0776
    -0.0081 (-0.74%)
     
  • BTC-GBP

    17,514.46
    -324.86 (-1.82%)
     
  • CMC Crypto 200

    432.42
    -12.11 (-2.72%)
     
  • S&P 500

    3,693.23
    -64.76 (-1.72%)
     
  • DOW

    29,590.41
    -486.29 (-1.62%)
     
  • CRUDE OIL

    78.20
    -0.54 (-0.69%)
     
  • GOLD FUTURES

    1,647.10
    -8.50 (-0.51%)
     
  • NIKKEI 225

    26,431.55
    -722.28 (-2.66%)
     
  • HANG SENG

    17,855.14
    -78.13 (-0.44%)
     
  • DAX

    12,288.08
    +3.89 (+0.03%)
     
  • CAC 40

    5,783.96
    +0.55 (+0.01%)
     

Global Retinal Imaging Devices Market Report 2022: Growing Prevalence of Diabetes Boosting Demand

·4-min read
Company Logo
Company Logo

Global Retinal Imaging Devices Market

Global Retinal Imaging Devices Market
Global Retinal Imaging Devices Market

Dublin, Sept. 07, 2022 (GLOBE NEWSWIRE) -- The "Retinal Imaging Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Device Type, and End-User" report has been added to ResearchAndMarkets.com's offering.

The retinal imaging devices market is projected to reach US$ 3.00 billion by 2028 from US$ 2.06 billion in 2021; it is estimated to grow at a CAGR of 5.6% during 2021-2028.

The report highlights trends prevailing in the market and factors driving its growth. The market's growth is attributed to the rising prevalence of eye diseases, growing global initiatives for blindness, and technological advancements. However, bulky size of the mydriatic camera makes it unsuitable for use high volume screening, critically impacting the overall market growth.

The growing prevalence of diabetes across the globe has resulted in the rising cases of diabetic retinopathy and blindness in adults. According to the International Diabetes Federation (IDF), data for 2021, nearly 537 million adults (20-79 years) are living with diabetes.

The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Three out of four adults with diabetes live in low- and middle-income countries. The report by IDF also stated the maximum portion of people in most of the countries is suffering from type 2 diabetes. Nearly 79% of the people living with type 2 diabetes are living in low and middle-income countries. Thus, such factors will result in the growth of cases related to diabetic retinopathy, which in turn will assist the retina imaging devices market over the forecast period.

Additionally, cataract and age-related macular degeneration (AMD) is significant cause of blindness across the world. A cataract is often untreated in developing countries due to limited access to qualified ophthalmologists and is responsible for nearly 50% of blindness in some countries.

Whereas, it is usually treated in developed countries. However, the leading cause of blindness in developed regions is age-related macular degeneration. For instance, according to the Human Development Index, data 2019, only 5% of people live with cataracts in countries such as the United States and the United Kingdom whereas, in Africa, approximately 65% of the population suffer from cataract-related issues. Penetration of low-cost retina imaging devices will spur the retinal imaging devices market during the forecast period.

Based on device type, the global retinal imaging devices market has been segmented into fluorescein angiography, fundus camera and optical coherence tomography (OCT).

The fundus camera segment held the largest share of the market in 2021. However, the optical coherence tomography segment is anticipated to register the highest CAGR of 8.1% in the market during the forecast period. The recent addition of OCT angiography allows dyeless visualization of retinal vessels in the macula. The OCT machines can capture good quality images even through dense cataracts.

Based on end-user, the global retinal imaging devices market is segmented into hospitals and clinics, specialty clinics, ambulatory care centers, and others. The hospitals & clinics segment held the largest share of the market in 2021 and specialized eye care centers is expected to register the highest CAGR of 6.6% in the market during the forecast period.

Market Dynamics

Key Market Drivers

  • Rising prevalence of eye diseases

  • Growing global initiatives for blindness

  • Technological advancements

Key Market Restraints

  • High cost of OCT devices

Key Market Opportunities

  • Opportunities to reduce cost of OCT devices

Future Trends

  • Integrating artificial intelligence in retinal imaging devices

Key Topics Covered:

1. Introduction

2. Retinal Imaging Device Market - Key Takeaways

3. Research Methodology

4. Retinal Imaging Device - Market Landscape

5. Retinal Imaging Device - Key Market Dynamics

6. Retinal Imaging Device Market - Global Analysis

7. Retinal Imaging Device Market Analysis - By Device Type

8. Retinal Imaging Device Market Analysis - By End User

9. Retinal Imaging Device Market - Geographic Analysis

10. Impact of COVID-19 Pandemic on Global Retinal Imaging Devices Market

11. Retinal Imaging Devices Market- Industry Landscape

12. Company Profiles

13. Appendix

Companies Mentioned

  • Carl Zeiss Meditec

  • Revenio Group Oyj

  • Nikon Corporation

  • Optomed

  • Topcon Corporation

  • Imagine Eyes

  • Epipole Ltd

  • Forus Health Pvt Ltd

  • Eyenuk Inc

  • Phoenix Technology Group LLC

For more information about this report visit https://www.researchandmarkets.com/r/nwjn4i

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900